Terms: = Ovarian cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
630 results:
1. Long non-coding RNA RAD51-AS1 promotes the tumorigenesis of ovarian cancer by elevating EIF5A2 expression.
Zhao L; Huang J; Liu W; Su X; Zhao B; Wang X; He X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):179. PubMed ID: 38584230
[TBL] [Abstract] [Full Text] [Related]
2. MATN2 overexpression suppresses tumor growth in ovarian cancer via PTEN/PI3K/AKT pathway.
Liu J; Zhang J; Zhang Y; Yang B; Liu H; Chen Y
Funct Integr Genomics; 2024 Apr; 24(2):71. PubMed ID: 38568332
[TBL] [Abstract] [Full Text] [Related]
3. Oncological outcomes of intraperitoneal chemotherapy in advanced ovarian cancer: BRCA mutation role.
Padilla-Iserte P; Iváñez M; Muruzabal JC; Navarro R; Díaz-Feijoo B; Iacoponi S; García-Pineda V; Díaz C; Utrilla-Layna J; Gil-Moreno A; Serra A; Gilabert-Estellés J; Martínez Canto C; Tejerizo Á; Lago V; Cárdenas-Rebollo JM; Domingo S;
Eur J Surg Oncol; 2024 Apr; 50(4):108263. PubMed ID: 38492526
[TBL] [Abstract] [Full Text] [Related]
4. PARP1-stabilised FOXQ1 promotes ovarian cancer progression by activating the LAMB3/WNT/β-catenin signalling pathway.
Wu J; Wu Y; Chen S; Guo Q; Shao Y; Liu C; Lin K; Wang S; Zhu J; Chen X; Ju X; Xia L; Wu X
Oncogene; 2024 Mar; 43(12):866-883. PubMed ID: 38297082
[TBL] [Abstract] [Full Text] [Related]
5. Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of ovarian cancer.
Wang JY; Gross M; Urban RR; Jorge S
Curr Treat Options Oncol; 2024 Mar; 25(3):313-329. PubMed ID: 38270801
[TBL] [Abstract] [Full Text] [Related]
6. Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in ovarian cancer Murine Xenografts.
Demuytere J; Carlier C; Van de Sande L; Hoorens A; De Clercq K; Giordano S; Morosi L; Matteo C; Zucchetti M; Davoli E; Van Dorpe J; Vervaet C; Ceelen W
Int J Nanomedicine; 2024; 19():429-440. PubMed ID: 38260242
[TBL] [Abstract] [Full Text] [Related]
7. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1.
Li YK; Gao AB; Zeng T; Liu D; Zhang QF; Ran XM; Tang ZZ; Li Y; Liu J; Zhang T; Shi GQ; Zhou WC; Zou WD; Peng J; Zhang J; Li H; Zou J
J Transl Med; 2024 Jan; 22(1):46. PubMed ID: 38212795
[TBL] [Abstract] [Full Text] [Related]
8. L-carnitine fails to rescue chemotherapy injured ovaries by epigenetic changes of transcription factors.
Ahmadpour S; Moshkdanian G; Rezvani Z; Almasi M
Gene; 2024 Apr; 901():148128. PubMed ID: 38181927
[TBL] [Abstract] [Full Text] [Related]
9. CCT2 prevented β-catenin proteasomal degradation to sustain cancer stem cell traits and promote tumor progression in epithelial ovarian cancer.
Chen J; Hu Q; Zhou C; Jin D
Mol Biol Rep; 2024 Jan; 51(1):54. PubMed ID: 38165547
[TBL] [Abstract] [Full Text] [Related]
10. OTU deubiquitinase 7B facilitates the hyperthermia-induced inhibition of lung cancer progression through enhancing Smac-mediated mitochondrial dysfunction.
Sun C; Bai J; Sun J; Sun Y; Zhang F; Li H; Liu Y; Meng L; Wang X
Environ Toxicol; 2024 Apr; 39(4):1989-2005. PubMed ID: 38088504
[TBL] [Abstract] [Full Text] [Related]
11. CO
Braet H; Fransen PP; Mariën R; Lollo G; Ceelen W; Vervaet C; Balcaen L; Vanhaecke F; Vanhove C; van der Vegte S; Gasthuys E; Vermeulen A; Dankers PYW; De Smedt SC; Remaut K
ACS Appl Mater Interfaces; 2023 Oct; 15(42):49022-49034. PubMed ID: 37819736
[TBL] [Abstract] [Full Text] [Related]
12. Hypoxia-associated genetic signature in ovarian steroid cell tumor NOS.
Chao A; Huang HJ; Lin CY; Lee CH; Lin CH; Chao AS; Lai CH; Chang TC; Wu KY; Wu RC
Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37655726
[TBL] [Abstract] [Full Text] [Related]
13. Cytoplasmic SIRT1 promotes paclitaxel resistance in ovarian carcinoma through increased formation and survival of polyploid giant cancer cells.
Xu H; Zeng S; Wang Y; Yang T; Wang M; Li X; He Y; Peng X; Li X; Qiao Q; Zhang J
J Pathol; 2023 Oct; 261(2):210-226. PubMed ID: 37565313
[TBL] [Abstract] [Full Text] [Related]
14. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession.
Guo Z; Guo L
Dig Liver Dis; 2024 Feb; 56(2):352-362. PubMed ID: 37429790
[TBL] [Abstract] [Full Text] [Related]
15. Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory ovarian cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial.
Holloway RW; Mendivil AA; Kendrick JE; Abaid LN; Brown JV; LeBlanc J; McKenzie ND; Mori KM; Ahmad S
JAMA Oncol; 2023 Jul; 9(7):903-908. PubMed ID: 37227734
[TBL] [Abstract] [Full Text] [Related]
16. Fibroblast Activation Protein-Targeted Radioligand Therapy for Treatment of Solid Tumors.
Lindeman SD; Mukkamala R; Horner A; Tudi P; Booth OC; Huff R; Hinsey J; Hovstadius A; Martone P; Zhang F; Srinivasarao M; Cox A; Low PS
J Nucl Med; 2023 May; 64(5):759-766. PubMed ID: 37116911
[TBL] [Abstract] [Full Text] [Related]
17. VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma.
Zhang Q; Li J; Chen Z; Jiang K; Yang K; Huang F; Huang A; Zhang X; Zhang J; Wang H
Cell Oncol (Dordr); 2023 Aug; 46(4):1001-1014. PubMed ID: 36929488
[TBL] [Abstract] [Full Text] [Related]
18. TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability.
Meng X; Cao J; Zheng H; Ma X; Wang Y; Tong Y; Xie S; Lu R; Guo L
Cancer Med; 2023 Apr; 12(8):9738-9748. PubMed ID: 36789877
[TBL] [Abstract] [Full Text] [Related]
19. UBE2E2 enhances Snail-mediated epithelial-mesenchymal transition and Nrf2-mediated antioxidant activity in ovarian cancer.
Hong X; Ma N; Li D; Zhang M; Dong W; Huang J; Ci X; Zhang S
Cell Death Dis; 2023 Feb; 14(2):100. PubMed ID: 36765041
[TBL] [Abstract] [Full Text] [Related]
20. Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.
Chai H; Pan C; Zhang M; Huo H; Shan H; Wu J
BMC Cancer; 2023 Jan; 23(1):96. PubMed ID: 36707804
[TBL] [Abstract] [Full Text] [Related]
[Next]
